An AP-1 enhancer mediates TPA-induced transcriptional activation of the chicken insulin-like growth factor I gene

Biochem Biophys Res Commun. 1993 Feb 15;190(3):767-73. doi: 10.1006/bbrc.1993.1115.

Abstract

As a step to elucidate a role of protein kinase C(PKC) pathways in the regulation of insulin-like growth factor I(IGF-I) gene, we sought to determine whether the IGF-I gene promoter of chicken can be a target of regulation by PKC. An initial gene transfer study showed that, in a human cell line HepG2, the IGF-I gene promoter directs accurate transcription of IGF-I-luciferase fusion gene and enhances luciferase activity. Treatment of transfected cells with 12-o-tetradecanoylphorbol 13-acetate(TPA) increased promoter activity of 2100 and 600bp 5'-flanking sequence 4.9- and 3.6-fold, respectively. Site-directed mutagenesis in the AP-1-like sequence located within the 600bp resulted in 91% loss of its TPA-induced promoter activity, and a gel mobility-shift analysis revealed that TPA-stimulation of HepG2 cells caused a dramatic increase in specific protein-binding to the AP-1-like sequence, suggesting that the sequence functions as an AP-1 enhancer. These observations support a direct role for PKC pathways in activating the IGF-I gene promoter in chicken.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Binding Sites
  • Chickens
  • DNA-Binding Proteins / metabolism
  • Enhancer Elements, Genetic*
  • Gene Expression Regulation*
  • Insulin-Like Growth Factor I / genetics*
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins c-jun / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Transcription, Genetic / drug effects*

Substances

  • DNA-Binding Proteins
  • Proto-Oncogene Proteins c-jun
  • Insulin-Like Growth Factor I
  • Tetradecanoylphorbol Acetate